ArticleThoracic cancer2026

RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin-Induced Apoptosis.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.